The majority of CHH patients with KLB mutations exhibit metabolic defects; 17% of CHH patients carry mutation(s) in FGF21/KLB/FGFR1 pathway, either as monoallelic or digenic combinations. This evidence concerns the gene KLB and cartilage-hair hypoplasia.